Natural porcine surfactant inhibits superoxide anions and proinflammatory mediators released by stimulated human monocytes.

被引:0
|
作者
Walti, H
Polla, BS
Bachelet, M
机构
[1] UFR COCHIN PORT ROYAL,LAB PHYSIOL RESP,PARIS,FRANCE
[2] UFR COCHIN PORT ROYAL,NICU,PARIS,FRANCE
关键词
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
引用
收藏
页码:1491 / 1491
页数:1
相关论文
共 15 条
  • [11] NPS2143 Inhibits MUC5AC and Proinflammatory Mediators in Cigarette Smoke Extract (CSE)-Stimulated Human Airway Epithelial Cells
    Jae-Won Lee
    Ji-Won Park
    Ok-Kyoung Kwon
    Hee Jae Lee
    Hye Gwang Jeong
    Jae-Hong Kim
    Sei-Ryang Oh
    Kyoung-Seop Ahn
    Inflammation, 2017, 40 : 184 - 194
  • [12] Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-κB phosphorylation and nuclear factor-κB transcriptional activity through nicotinic acetylcholine receptor α7
    Yoshikawa, H.
    Kurokawa, M.
    Ozaki, N.
    Nara, K.
    Atou, K.
    Takada, E.
    Kamochi, H.
    Suzuki, N.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 146 (01): : 116 - 123
  • [13] Natural Porcine Surfactant (Curosurf®) Down-Regulates mRNA of Tumor Necrosis Factor-α (TNF-α) and TNF-α Type II Receptor in Lipopolysaccharide-Stimulated Monocytes
    Frank M Baur
    Birgit Brenner
    Bettina Goetze-Speer
    Stefan Neu
    Christian P Speer
    Pediatric Research, 1998, 44 : 32 - 36
  • [14] Natural porcine surfactant (Curosurf®) down-regulates mRNA of tumor necrosis factor-α (TNF-α) and TNF-α type II receptor in lipopolysaccharide-stimulated monocytes
    Baur, FM
    Brenner, B
    Goetze-Speer, B
    Neu, S
    Speer, CP
    PEDIATRIC RESEARCH, 1998, 44 (01) : 32 - 36
  • [15] Effect of natural porcine surfactant in Staphylococcus aureus induced pro-inflammatory cytokines and reactive oxygen species generation in monocytes and neutrophils from human blood
    Lugones Ladron de Guevara, Yuliannis
    Blanco Hidalgo, Odalys
    Santos, Sidneia Sousa
    Colo Brunialti, Milena Karim
    Faure, Roberto
    Salomao, Reinaldo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2014, 21 (02) : 369 - 374